Healthcare Triangle Strengthens Global Presence with Teyame AI Acquisition, Projected $38M Revenue Boost

Healthcare Triangle Expands its Global Footprint through Acquisition of Teyame AI

In a significant move towards enhancing its market position, Healthcare Triangle, Inc. (Nasdaq: HCTI) has announced a definitive agreement to acquire Teyame AI LLC. Based in the picturesque Caribbean nation of St Kitts and Nevis, Teyame AI is well-regarded for its pioneering artificial intelligence solutions aimed at transforming customer engagement within various industries.

Strategic Objectives

This acquisition aligns with HCTI's strategic goals of expanding its SaaS capabilities across Europe and Latin America, promising to generate an estimated $38 million in additional revenue and an EBITDA boost of about $5 million. David Ayanoglou, the Chief Financial Officer of HCTI, emphasized the transformative potential of this partnership, stating, "The transaction will bring real-world experience of Agentic Gen AI and will change the game for HCTI. It's where the rubber meets the road in AI."

Financial Overview

The transaction includes an estimated total consideration of approximately $50 million, funded through a mix of cash, common stock, and convertible preferred stock, along with potential earnout-based equity considerations. The deal is expected to close on January 29, 2026, pending shareholder approval and customary closing conditions. Interestingly, the agreement will be effective retroactively from January 1, 2026, indicating a readiness to integrate Teyame’s advanced offerings into HCTI's operations.

Increasing Market Reach

Headquartered in Madrid, Teyame AI has established itself as a leader in AI-driven customer experience solutions, serving clients in the banking and insurance sectors, and piloting innovative applications within healthcare contexts. Innovative features of Teyame’s technology stack include advanced chatbots, multilingual support for patient engagement, and real-time data analytics capabilities—elements that can be synergistically enhanced when integrated with HCTI’s healthcare technologies.

Enhancing Patient Engagement

The union aims to create a sophisticated ecosystem that focuses on personalized, outcome-oriented patient interactions. Sujatha Ramesh, Chief Operating Officer of HCTI, stated, "Integrating these AI-powered engagement platforms with HCTI's healthcare technologies positions us to deliver a next-generation, intelligent ecosystem for patients and providers, while also expanding our SaaS footprint internationally."

Looking Ahead

This acquisition is part of a broader initiative by HCTI to drive innovation in AI-backed healthcare services, focusing on developing intelligent global platforms that enhance patient engagement and care management. As the landscape of healthcare continues to evolve, the synthesis of HCTI’s existing technology with Teyame’s AI solutions marks a pivotal evolution for the company, steering it towards a future where data-driven healthcare is at the forefront.

Conclusion

Healthcare Triangle’s strategic decision to acquire Teyame AI illustrates its commitment to leading the charge in AI-driven healthcare innovation. This partnership not only strengthens HCTI’s position within the healthcare sector but also heralds an era of intelligent, integrated patient care that harnesses the power of artificial intelligence. As stakeholders look forward to the realization of this strategic expansion, both companies are well-positioned to redefine the standards of patient engagement in the healthcare landscape.